1. A substrate storage container including:
a container body;
a door for opening and closing the container body;
a valve unit attached to a through-hole formed in the container body for regulating the gas flow with respect to the container body, characterized in that the valve unit comprises:
a fixed sleeve for gas flow, fitted in the through-hole;
a holding sleeve for gas flow, mated with the fixed sleeve;
an elastic check valve built in between the fixed sleeve and the holding sleeve; and
an interior lid sleeve for gas flow, opposing the elastic check valve, and one of the fixed sleeve and the interior lid sleeve is adapted to be opened and closed by the elastic check valve, so that gas will pass through when the elastic check valve is open while gas will be prevented from passing when the elastic check valve is closed; and
a hollow nozzle tower communicating with the valve unit is made to stand, the peripheral wall thereof being formed with gas ejection holes.
2. The substrate storage container according to claim 1, wherein the valve unit as a gas inlet valve or gas discharge valve is fitted to the through-hole.
3. The substrate storage container according to claim 1, wherein a rib is formed and extended outward from the periphery of the through-hole and the fixed sleeve is formed with a flange that is in contact with the periphery of the rib while the holding sleeve is formed with a flange that is in contact with the periphery of the through-hole.
4. The substrate storage container according to claim 1, wherein a clearance for gas flow is formed at least between the holding sleeve and the periphery of the elastic check valve.
5. The substrate storage container according to claim 1, wherein the interior lid sleeve is fitted in the holding sleeve with an air filter interposed therebetween.
6. The substrate storage container according to claim 1, wherein the elastic check valve is at least made up of a check valve that is built in the fixed sleeve, leaving a clearance, and an elastically deformable element interposed between the check valve and the interior lid sleeve, and the opening of the fixed sleeve is adapted to be opened and closed by the check valve, so that gas will pass through when the check valve is open while gas will be prevented from passing when the check valve is closed.
7. The substrate storage container according to claim 1, wherein the elastic check valve is at least made up of a check valve that is built in the fixed sleeve, leaving a clearance, and an elastically deformable element interposed between the check valve and the fixed sleeve, and the opening of the interior lid sleeve is adapted to be opened and closed by the check valve, so that gas will pass through when the check valve is open while gas will be prevented from passing when the check valve is closed.
8. The substrate storage container according to claim 1, wherein the elastic check valve is at least made up of a check valve that is built in the fixed sleeve, leaving a clearance, and an elastically deformable element for the check valve, and either the check valve or the elastically deformable element is made in contact with the interior lid sleeve, so that gas will pass through when the check valve is open while gas will be prevented from passing when the check valve is closed.
9. The substrate storage container according to claim 6, wherein a guide element is provided for either the check valve of the elastic check valve or the interior lid sleeve while a guided part is provided for the other, so that the guide element and the guided part fit to each other in a slidably manner.
10. The substrate storage container according to claim 9, wherein the guide element is formed in the interior lid sleeve so as to have an approximately convex-top section while the guided part is formed in the check valve of the elastic check valve so as to have an approximately concave-top section.
11. The substrate storage container according to claim 6, wherein a sealing element is attached to the check valve of the elastic check valve, and the sealing element is placed into deforming contact with the opening of the fixed sleeve or the interior lid sleeve to seal.
12-13. (canceled)
14. The substrate storage container according to claim 1, wherein the elastic check valve is at least made up of a check valve that is built in the fixed sleeve, leaving a clearance and an extensible bellows fitted in the check valve, the peripheral wall of the bellows is formed with a passage opening, and the check valve can be opened and closed by the extension and compression of the bellows.
15. The substrate storage container according to claim 1, wherein the elastic check valve is at least made up of a check valve that is built in the fixed sleeve, leaving a clearance and an elastic skirt body integrated with the check valve, a passage opening is formed in the check valve, an approximately cylindrical skirt piece is flexibly extended from the rim of the skirt body and is fitted on the periphery of the check valve, and the check valve can be opened and closed by the deformation of the skirt body.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method for inhibiting pathological vascular proliferation wherein the method comprises administering, to a site of vascular proliferation, the dipeptide arginyl-glutamine, or a salt thereof.
2. The method, according to claim 1, used to treat pathological ocular vascular proliferation.
3. The method, according to claim 2, wherein the vascular proliferation is associated with retinopathy of prematurity or diabetic retinopathy.
4. The method, according to claim 1, wherein the vascular proliferation is associated with tumor growth.
5. The method, according to claim 1, wherein the vascular proliferation being inhibited is in a mammal.
6. The method, according to claim 5, which comprises local administration of the dipeptide, or a salt or prodrug thereof.
7. The method, according to claim 5, which comprises systemic administration of the dipeptide, or a salt or prodrug thereof.
8. The method, according to claim 7, wherein the administration is enteral.
9. The method, according to claim 5, which comprises administering to a mammal a prodrug that is broken down to the dipeptide.
10. The method, according to claim 5, which comprises oral consumption by the mammal of the dipeptide, or a salt or prodrug thereof.
11. The method, according to claim 1, wherein said dipeptide, or salt thereof, is administered in an aqueous formulation.
12. The method, according to claim 1, which further comprises the administration of a second therapeutic compound.
13. The method, according to claim 1, used to treat an angiogenic disease in a mammal.
14. The method, according to claim 13, wherein said mammal is a human.
15. A pharmaceutical composition consisting essentially of an arginyl-glutamine dipeptide, or a salt or prodrug thereof, and a pharmaceutically acceptable varrier.
16. A formulation for enteral administration for the prevention or treatment of a condition that is selected from retinopathy of prematurity, diabetic retinopathy, vascular proliferative retinopathy, or proliferation of abnormal vascularization, where the formulation comprises arginyl-glutamine dipeptide, or a precursor thereof.
17. The formulation according to claim 16, wherein the amount of the arginyl-glutamine dipeptide, or precursor thereof, is sufficient to treat or prevent the condition.
18. A method for the prevention or treatment of a condition that is selected from retinopathy of prematurity, diabetic retinopathy, vascular proliferative retinopathy, or proliferation of abnormal vascularization, in a patient, the method comprising enterally administering to the patient a composition comprising arginyl-glutamine dipeptide, or precursor thereof, in an amount that is sufficient to treat or prevent the condition.